Les nouveaux médicaments en cancérologie

Over recent years, active research in oncology has led to the arrival on the market of numerous drugs, particularly targeted antineoplastic therapies. Administered orally, these medicines have an acceptable tolerance compared to cytotoxic chemotherapies. However, when they are dispensed, patients must be given expert and accurate advice, in order to favour compliance.